Core Viewpoint - Green Thumb Industries Inc. reported a quarterly loss of $0.01 per share, missing the Zacks Consensus Estimate of $0.04, and showing a decline from earnings of $0.09 per share a year ago, indicating an earnings surprise of -125.00% [1] Financial Performance - The company posted revenues of $293.26 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 4.56%, and showing an increase from year-ago revenues of $280.15 million [2] - Over the last four quarters, Green Thumb Industries has not surpassed consensus EPS estimates, but has topped consensus revenue estimates three times [2] Stock Performance - Green Thumb Industries shares have declined approximately 11.6% since the beginning of the year, contrasting with the S&P 500's gain of 7.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.04 on revenues of $285.85 million, and for the current fiscal year, it is $0.15 on revenues of $1.14 billion [7] Industry Outlook - The Medical - Products industry, to which Green Thumb Industries belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, suggesting potential challenges ahead [8] - The performance of the stock may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Core Insights - Green Thumb Industries reported a revenue of $293 million for Q2 2025, reflecting a 5% increase compared to the same period last year [4][5][9] - The company experienced a GAAP net loss of $0.65 million, or $0.01 per share, but would have reported a net income of $11 million, or $0.05 per share, excluding a one-time loss [10][9] - Adjusted EBITDA for the quarter was $82.7 million, representing 28.2% of revenue, down from 33.5% in the same quarter of the previous year [11][9] Financial Overview - Total revenue for Q2 2025 was $293.3 million, up 4.7% from the prior year, driven by the Consumer Packaged Goods segment [5][9] - Gross profit was $146.3 million, or 49.9% of revenue, down from 53.7% in the prior year, primarily due to price compression [7][9] - Selling, general, and administrative expenses increased to $106.8 million, or 36.4% of revenue, compared to 34.4% in Q2 2024 [8][9] Market Performance - Comparable sales decreased by 4.1% year-over-year across 91 stores, while overall retail revenue increased by 0.3% [6][9] - The company gained market share in key states such as Illinois, Pennsylvania, New Jersey, and Florida [4] Capital Allocation - Green Thumb repurchased approximately 5.6 million shares for $24 million at an average price of $4.28 per share during the quarter [14][9] - The total cash at the end of the quarter was $177 million, with total debt outstanding at $250 million [13][9] Balance Sheet and Liquidity - As of June 30, 2025, total assets were $2.55 billion, with total equity of $1.80 billion [13][25] - Current assets included cash and cash equivalents of $176.9 million [13][25]

Core Insights - Marijuana stock investors are currently facing uncertainty due to a lack of upward trading momentum, but some view the downtrend as an opportunity for future gains [1] - The potential for upward trading is often linked to news of federal reform regarding cannabis, which historically boosts investor confidence and stock prices [2][3] - Recent political developments, including Donald Trump's support for federal legislation, could influence future trading dynamics in the cannabis sector [3] Company Highlights - **Trulieve Cannabis Corp.**: Operates as a cannabis retailer, cultivating, processing, and distributing cannabis products through dispensaries and home delivery [4] - Recent expansion of Trulieve's product line includes the launch of Onward and Upward beverages, which are compliant with the Farm Bill and available in Florida and Illinois [6] - **Green Thumb Industries Inc.**: Engages in the manufacturing, distribution, marketing, and sale of cannabis products for both medical and adult-use markets in the U.S., operating through Retail and Consumer Packaged Goods segments [7] Upcoming Events - Green Thumb Industries is set to host a conference call on August 6, 2025, to discuss its Q2 2025 earnings [10]

Industry Overview - The U.S. cannabis industry is projected to surpass $44 billion in total sales by 2025, driven by adult-use markets in over 20 states and increasing demand for cannabis wellness products [1] - The industry supports hundreds of thousands of jobs, and despite federal delays, state-level progress continues to drive momentum [1] - Market sentiment fluctuates with cannabis reform discussions, creating both opportunities and uncertainty for traders [2] Company Highlights - AYR Wellness Inc. operates over 90 dispensaries across several major U.S. markets, focusing on premium cannabis brands and in-house product manufacturing [5] - Green Thumb Industries Inc. operates in 15 states with over 140 dispensary licenses, known for its consistent execution and financial discipline [9] - Verano Holdings Corp. operates over 135 dispensaries and emphasizes quality control and sustainable practices, with a strong presence in Florida [13] Financial Performance - AYR Wellness reported Q1 2025 revenue of $114.4 million, a 3% year-over-year increase, with an adjusted EBITDA margin of 23% [8] - Green Thumb Industries reported Q1 2025 revenue of $254.1 million, a 5.4% increase from the previous year, achieving a net income of $11.1 million [10][12] - Verano Holdings reported Q1 2025 revenue of $237 million, with an adjusted EBITDA margin of 28% and a net loss of $9.2 million, an improvement from the previous quarter [15] Investment Opportunities - Traders are focusing on technical analysis to identify potential breakouts in marijuana stocks, with key support and resistance levels being tested [2][3] - AYR Wellness, Green Thumb Industries, and Verano Holdings are highlighted as top stocks to watch for potential gains in the second half of 2025 [16]

Industry Overview - The cannabis industry has faced challenges, with the market value dropping from projections of $30 billion to below that figure, yet there remains optimism for future growth due to potential federal reforms [2] - Current market conditions have led to a decline in marijuana stock prices, presenting potential entry points for investors [3] Company Highlights - **Green Thumb Industries Inc.**: Engaged in manufacturing, distributing, and selling cannabis products for medical and adult-use markets in the U.S. The company is set to hold a Q2 2025 earnings conference call on August 6, 2025 [4][6] - **Greenlane Holdings, Inc.**: Focuses on the development and distribution of cannabis accessories and lifestyle products. Recently selected JointCommerce as its B2C e-commerce digital marketing platform to enhance growth [7][8] - **Planet 13 Holdings Inc.**: Cultivates and provides cannabis products for medical and retail markets in the U.S. The company will report its Q2 2025 earnings on August 13, 2025, with a conference call to discuss financial results and business strategy [9][11]

Industry Overview - The U.S. cannabis industry is projected to reach approximately $39 billion in sales across medical and recreational markets in 2024, with analysts expecting consistent double-digit growth through the end of the decade [1] - Despite ongoing regulatory uncertainty, the sector continues to evolve as legalization gains ground and consumer demand grows [5] Penny Stocks Focus - Investors are currently focusing on marijuana penny stocks due to their explosive potential, which often react strongly to news, earnings, and market momentum [1] - Technical analysis is crucial for trading penny stocks, with traders monitoring volume surges, trendline breaks, and key support levels [2][4] Key Companies Planet 13 Holdings Inc. (PLNH) - Planet 13 is recognized for its Las Vegas SuperStore, which combines entertainment and retail, attracting both tourists and locals [6][10] - The company reported Q1 2025 revenue of approximately $25.7 million, with a gross profit of $11.6 million, resulting in a 45.1% gross margin [11] - Planet 13 operates nine dispensaries and is expanding in both recreational and medical markets, with expectations for revenue growth in the second half of 2025 [8][11] Cansortium Inc. (CNTMF) - Cansortium operates under the Fluent Cannabis Care brand and focuses on Florida's medical cannabis market, with 35 dispensaries in the state [12][14] - The company reported Q1 2025 revenue of $24.2 million, with a gross margin improvement to 57% [15] - Cansortium is positioned for future growth with plans to expand into Texas and Pennsylvania once regulations allow [14][15] Green Thumb Industries Inc. (GTBIF) - Green Thumb is one of the largest multi-state cannabis operators in the U.S., with over 100 dispensaries across 14 states [16][19] - The company posted Q1 2025 revenue of $280 million, reflecting a year-over-year increase of 1.5%, with a gross profit margin of 51.3% [20] - Green Thumb emphasizes cash preservation and long-term sustainability, maintaining a forecast for moderate growth in 2025 [20] Market Dynamics - Momentum in marijuana reform is a significant driver for the sector, with states expanding access despite the lack of federal legalization [3] - Technical setups combined with fundamental research can provide strong risk-reward scenarios for investors in the cannabis market [21]

Industry Overview - The cannabis sector has experienced a steady decline, but there are indications that the future for marijuana stocks could improve [1] - Many companies are showing success and profitability, yet this has not significantly impacted the public sector [1] - The industry is awaiting federal reforms, such as rescheduling or banking reform, to create a more efficient and compliant market [2] Market Potential - Almost every state in the US has legalized cannabis, along with several global regions, indicating a growing market [2] - Canada is also a significant market, and there is a positive outlook for potential gains in the cannabis sector [3] Company Highlights - **Trulieve Cannabis Corp.**: Operates as a cannabis retailer, cultivating, processing, and distributing cannabis products. The company has filed a shelf registration statement with the SEC [4][6] - **Green Thumb Industries Inc.**: Manufactures and sells cannabis products for medical and adult use in the US, operating through Retail and Consumer Packaged Goods segments [6] Upcoming Events - Trulieve will hold a Q2 2024 conference call on August 6 to discuss its results [6] - Green Thumb Industries will release its second quarter 2025 financial results after the market closes on August 6, 2025, followed by a conference call [9]

Market Overview - The Legal Cannabis Market has grown from USD 33.52 billion in 2024 to USD 42.91 billion in 2025, with a projected value of USD 144.18 billion by 2030, reflecting a compound annual growth rate (CAGR) of 27.52% [2][11]. - The market evolution is driven by legislative changes, consumer behavior, and technological advancements [2]. Industry Dynamics - Legislative changes and increasing consumer acceptance have led to a diverse range of products, including extracts and edibles, while regulatory bodies are enhancing quality control measures [3]. - Vertical integration and partnerships are essential for achieving scale and distribution advantages, with advances in cultivation improving yields and consistency [4]. - Federal developments are fostering optimism regarding interstate commerce and harmonized licensing and taxation frameworks [5]. Investment Trends - There is a noticeable shift towards ancillary services and strategic mergers and acquisitions, which are reshaping competitive landscapes and refining value creation across the supply chain [6]. - Decision-makers are gaining strategic insights to identify opportunities amid evolving consumer preferences and technological advancements [6]. Tariff Impact - New tariff structures in 2025 have increased costs for cultivation and processing, leading to reassessments of manufacturing locations and supplier networks [8]. - Retailers are facing margin pressures due to increased duties on imported machinery and packaging components, often passing costs to consumers [9]. - Regional operators are diversifying sourcing strategies to mitigate future tariff effects, fostering collaborative partnerships to maintain resilience [9]. Key Report Attributes - The report spans 193 pages, covering the forecast period from 2025 to 2030, with an estimated market value of USD 42.91 billion in 2025 and a forecasted value of USD 144.18 billion by 2030 [11].

Core Viewpoint - Green Thumb Industries Inc. will release its second quarter 2025 financial results on August 6, 2025, after market close [1] Group 1: Financial Results Announcement - The financial results will be discussed in a conference call and audio webcast on August 6, 2025, at 5:00 p.m. Eastern Time [2] - Participants can pre-register for the live conference call through a provided link [3] Group 2: Company Overview - Green Thumb Industries is a national cannabis consumer packaged goods company and retailer, promoting well-being through cannabis [4] - The company manufactures and distributes a portfolio of branded cannabis products and operates RISE retail locations [4] - Green Thumb has 20 manufacturing facilities, 105 retail locations, and operates in 14 U.S. markets, employing approximately 4,900 people [4]

Core Viewpoint - Green Thumb Industries Inc. is hosting the third annual "The Miracle in Mundelein," a cannabis and music festival, on September 6 and 7, 2025, in Mundelein, Illinois, featuring legal on-site cannabis consumption and a diverse lineup of musical performances [2][3][7]. Event Details - The festival will take place across from RISE Dispensaries and will include performances from notable artists such as Damian "Jr. Gong" Marley, De La Soul, Umphrey's McGee, and Dark Star Orchestra [4][5][9]. - General admission and VIP tickets will be available starting June 6, 2025, with prices starting at $59 for single-day general admission and $313 for two-day VIP passes [8]. Cannabis Experience - Attendees can expect immersive experiences including dab bars and joint rolling stations featuring premium RYTHM products, as well as the Señorita THC Margarita Cabana Club [6][7]. - The event is strictly for individuals aged 21 and older, with cannabis available for purchase at RISE Dispensary Mundelein and on festival grounds [5][6]. Company Background - Green Thumb Industries is a national cannabis consumer packaged goods company that operates RISE Dispensaries and offers a range of branded cannabis products [9]. - The company has 20 manufacturing facilities and 104 retail locations across 14 U.S. markets, employing approximately 4,900 people [9].